viral
respiratori
tract
infect
vrti
import
caus
morbid
mortal
patient
hematolog
malign
particularli
allogen
haematopoiet
stem
cell
transplant
hsct
recipi
immunocompromis
patient
vrti
usual
sever
increas
risk
progress
upper
lower
respiratori
tract
infect
frequent
presenc
bacteri
fungal
copathogen
immunocompet
patient
moreov
longterm
sequela
vrti
restrict
obstruct
airway
diseas
report
last
decad
rapid
highli
sensit
molecular
test
develop
made
avail
recent
multiplex
polymeras
chain
reaction
pcr
platform
detect
multipl
viral
pathogen
base
data
observ
studi
believ
vrti
patient
haematolog
malign
present
fever
andor
upper
respiratori
tract
symptom
less
known
asymptomat
circul
respiratori
virus
even
though
prolong
viral
shed
observ
influenza
infect
manag
strategi
base
presenc
influenzalik
ill
syndrom
ili
success
use
epidemiolog
treatment
studi
immunocompet
patient
hsct
recipi
increas
risk
develop
sever
influenza
complic
postexposur
gener
chemoprophylaxi
influenza
season
recommend
nevertheless
efficaci
impact
strategi
particularli
compar
earli
diagnosi
treatment
remain
unknown
aim
studi
prospect
evalu
incid
morbid
sever
vrti
outpati
hsct
unit
influenza
season
addit
clinic
use
presenc
ili
diagnos
treat
vrti
possibl
occurr
nosocomi
transmiss
microepidem
evalu
prospect
studi
season
influenza
outbreak
ie
januari
march
includ
adult
outpati
seen
least
month
hsct
unit
subject
allogen
hsct
recipi
patient
either
receiv
autolog
hsct
chemotherapi
haematolog
diseas
follow
data
record
demograph
type
underli
diseas
date
type
hsct
includ
condit
regimen
inform
consent
obtain
accord
declar
helsinki
asymptomat
symptomat
vrti
patient
underw
clinic
evalu
everi
visit
outpati
unit
invit
contact
physician
new
symptom
develop
addit
influenza
vaccin
statu
patient
household
contact
note
pharyng
swab
specimen
consid
suitabl
easili
collect
recent
recommend
collect
viral
test
first
visit
case
new
vrti
symptom
addit
swab
obtain
patient
vrti
order
document
resolut
infect
prolong
viral
shed
includ
analysi
bronchoalveolar
lavag
bal
fluid
clinic
respiratori
specimen
collect
clinic
indic
distribut
influenza
case
ie
begin
peak
end
epidem
cohort
compar
data
avail
itali
report
weekli
italian
network
influenza
surveil
superior
health
institut
ili
syndrom
defin
presenc
fever
plu
least
one
follow
symptom
cough
sore
throat
rhinorrhoea
andor
system
symptom
headach
asthenia
malais
arthromyalgia
absenc
document
caus
vrti
consid
detect
respiratori
viru
upper
lower
respiratori
tract
similar
european
centr
diseas
prevent
control
ecdc
definit
haematolog
patient
confirm
case
viral
respiratori
tract
infecti
diseas
defin
new
onset
symptom
least
one
follow
cough
coryza
sore
throat
short
breath
clinician
judgment
ill
due
infect
repeat
detect
viru
patient
consid
infect
episod
first
posit
swab
consid
coinfect
defin
simultan
detect
one
viru
separ
infect
episod
diagnos
new
viru
detect
onset
new
respiratori
symptom
asymptomat
infect
defin
detect
viru
patient
upper
respiratori
tract
sampl
without
symptom
respiratori
ill
upper
vrti
defin
respiratori
viral
isol
pharyng
swab
includ
symptomat
asymptomat
infect
upper
vrti
symptom
includ
sore
throat
cough
rhinorrhoea
nasal
congest
lower
vrti
defin
clinic
radiolog
confirm
pneumonia
detect
viru
lower
respiratori
tract
bal
fluid
direct
contact
period
least
h
patient
upper
lower
vrti
regard
exposit
vrti
case
molecular
assay
perform
region
refer
laboratori
oper
monday
friday
specimen
transport
univers
transport
medium
copan
italia
spa
brescia
itali
collect
subject
rna
extract
accord
manufactur
instruct
viral
rna
extract
spin
column
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
convert
random
hexamerprim
cdna
revertaid
system
fermenta
york
uk
store
use
cdna
prepar
subject
seeplex
ace
detect
pcr
kit
procedur
seegen
seoul
south
korea
multiplex
pcr
assay
allow
simultan
detect
respiratori
virus
influenza
ab
human
adenoviru
respiratori
syncyti
viru
rsv
ab
human
metapneumoviru
viru
human
parainfluenza
viru
human
rhinoviru
ab
human
coronaviru
sampl
posit
gene
flu
center
diseas
control
prevent
cdc
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
type
use
realtim
rtpcrbase
kit
establish
cdc
specif
detect
character
given
higher
sensit
cdc
rtpcr
system
seeplex
kit
detect
influenza
virus
gener
throughout
paper
result
pertain
influenza
viru
consid
obtain
former
method
small
number
influenza
viru
posit
sampl
untyp
low
viral
load
perform
multiplex
assay
determin
elsewher
outpati
unit
patient
visitor
healthcar
worker
requir
use
surgic
mask
wash
hand
patient
contact
routin
outpati
receiv
intraven
treatment
threepati
fivepati
room
order
reduc
possibl
nosocomi
transmiss
facilit
evalu
potenti
microepidem
patient
alway
place
room
unless
vrti
detect
patient
vrti
place
individu
room
asymptomat
feasibl
neg
respiratori
virus
yearli
influenza
vaccin
patient
hospit
staff
famili
member
recommend
differ
group
assess
mean
chisquar
test
heterogen
fisher
exact
test
appropri
p
valu
twosid
p
valu
consid
statist
signific
analys
perform
use
spss
version
statist
packag
spss
inc
chicago
il
usa
total
patient
screen
pharyng
swab
perform
among
patient
swab
perform
fiftysix
percent
patient
male
major
receiv
hsct
allogen
autolog
median
day
entri
studi
rang
day
particular
receiv
transplant
within
day
within
day
within
day
among
pharyng
swab
came
symptomat
patient
asymptomat
patient
total
swab
posit
virus
recov
case
symptom
virolog
document
infect
significantli
frequent
swab
perform
symptom
posit
compar
swab
asymptomat
subject
p
main
virus
detect
influenza
sampl
rsv
rhinoviru
influenza
rsv
infect
significantli
frequent
symptomat
subject
tabl
symptom
vrti
divid
three
main
categori
rate
posit
virolog
result
follow
ili
fever
upper
vrti
symptom
fig
classic
ili
present
significantli
frequent
associ
virolog
document
infect
compar
upper
vrti
symptom
group
vs
p
consid
ecdc
definit
less
specif
ili
patient
fulfil
criteria
viral
respiratori
tract
infecti
diseas
microbiolog
confirm
infect
case
influenza
patient
present
ili
fever
upper
vrti
symptom
asymptomat
patient
vaccin
evalu
predict
valu
ili
diagnosi
influenza
symptomat
patient
epidem
season
case
present
ili
influenza
patient
ili
vrti
rsv
patient
rhinoviru
patient
coronaviru
patient
infect
patient
ili
viru
detect
thu
sensit
ili
influenza
popul
confid
interv
ci
specif
ci
posit
predict
valu
ppv
ci
among
hsct
recipi
predict
valu
ili
influenza
case
present
ili
six
patient
pneumonia
thu
bal
perform
four
virus
detect
copathogen
report
tabl
one
influenza
two
rsv
one
coronaviru
two
case
influenza
rsv
progress
upper
lower
respiratori
tract
infect
diagnos
progress
rate
influenza
progress
rate
rsv
three
patient
influenza
rsv
pneumonia
success
treat
oseltamivir
ribavirin
respect
two
patient
diagnos
pneumonia
due
pathogen
weekli
incid
vrti
per
patientweek
influenza
per
patientweek
rsv
per
patientweek
analysi
weekli
distribut
diagnos
vrti
document
peak
activ
main
two
virus
influenza
rsv
detect
period
circul
influenza
viru
cohort
detect
later
detect
week
peak
activ
week
compar
gener
popul
detect
week
week
peak
activ
week
similar
delay
circul
detect
rsv
studi
popul
week
peak
activ
week
gener
popul
week
week
total
vrti
identif
virus
occur
outpati
incid
incid
influenza
rsv
infect
respect
incid
vrti
similar
hsct
recipi
patient
haematolog
malign
transplant
p
three
hsct
recipi
develop
second
episod
vrti
parainfluenza
day
later
rsv
influenza
day
later
coronaviru
coronaviru
day
later
rhinoviru
distribut
differ
vrti
report
fig
patient
characterist
outcom
four
group
vrti
outlin
tabl
particular
approxim
half
patient
either
follow
infect
influenza
rsv
rhinoviru
present
ili
syndrom
respect
standard
prevent
measur
includ
facial
mask
hand
hygien
appli
patient
vrti
influenza
infect
possibl
give
pharmacolog
prophylaxi
oseltamivir
evalu
contact
patient
document
influenza
infect
among
influenza
infect
treat
full
dose
oseltamivir
patient
treat
posit
result
avail
h
patient
asymptomat
vaccin
previou
allogen
hsct
wellcontrol
underli
diseas
overal
contact
case
identifi
among
outpati
symptomat
receiv
oseltamivir
treatment
pend
result
viral
test
wherea
asymptomat
among
receiv
oseltamivir
prophylaxi
within
h
exposur
contact
patient
remain
patient
close
monitor
develop
sign
symptom
influenza
infect
prophylaxi
given
decis
withhold
prophylaxi
base
either
fact
h
elaps
contact
notif
low
risk
sever
infect
lymphopenia
none
contact
develop
microbiolog
document
influenza
infect
despit
high
number
patient
expos
influenza
nosocomi
outbreak
detect
cluster
influenza
infect
observ
week
five
patient
day
identifi
type
virus
differ
three
type
one
type
one
type
b
evid
nosocomi
contact
patient
infect
type
day
transmiss
healthcar
worker
visitor
could
assess
swab
perform
among
healthcar
worker
attend
outpati
unit
respiratori
symptom
fever
studi
period
visitor
access
outpati
therapi
room
rsv
peak
activ
observ
week
seven
infect
equal
circul
four
b
three
subtyp
contact
patient
involv
make
unlik
patienttopati
transmiss
larg
epidem
outbreak
overal
patient
vaccin
season
strain
among
nonvaccin
patient
report
household
contact
vaccin
statist
signific
differ
incid
influenza
vaccin
nonvaccin
patient
p
patient
without
vaccin
household
contact
p
among
vaccin
patient
allogen
hsct
recipi
transplant
asymptomat
infect
classic
ili
fever
compar
nonvaccin
patient
symptomat
particular
ili
group
hsct
recipi
vaccin
rate
within
month
transplant
among
month
transplant
among
seven
autolog
transplant
recipi
one
vaccin
none
develop
influenza
incid
influenza
among
patient
month
transplant
among
month
transplant
vaccin
among
month
transplant
vaccin
prospect
studi
confirm
vrti
common
caus
morbid
affect
observ
period
month
almost
one
third
outpati
hsct
unit
asymptomat
vrti
infrequ
none
develop
clinic
signific
diseas
symptom
influenza
rsv
rhinoviru
infect
similar
classic
symptom
low
ppv
influenza
thu
rapid
reliabl
diagnosi
crucial
fortun
larg
outbreak
detect
low
rate
progress
upper
lower
respiratori
tract
infect
vrtirel
mortal
observ
presenc
symptom
significantli
associ
confirm
vrti
popul
classic
ili
low
ppv
vrti
includ
influenza
similar
result
report
anoth
prospect
observ
studi
patient
vrti
respiratori
virus
detect
frequent
presenc
symptom
symptom
case
influenza
vrti
similar
ecdc
definit
adapt
haematolog
popul
even
less
specif
ili
immunocompet
individu
ili
present
consid
rather
specif
influenza
epidem
season
fact
gener
healthi
older
adolesc
adult
live
area
confirm
influenza
viru
circul
estim
ppv
simpl
clinic
definit
influenza
acut
onset
cough
fever
report
approxim
empir
antiinfluenza
treatment
recommend
condit
howev
even
immunocompet
popul
accuraci
clinic
diagnosi
influenza
basi
symptom
alon
question
report
incid
ili
patient
influenza
consid
limit
symptom
ill
caus
pathogen
overlap
consider
influenza
immunocompromis
patient
associ
ili
influenza
even
less
pronounc
system
symptom
fever
myalgia
frequent
lack
therefor
consid
cocircul
influenza
rsv
rhinovirus
period
similar
clinic
present
infect
earli
use
rapid
molecular
test
identifi
specif
viru
instead
univers
empir
treatment
antiinfluenza
drug
patient
ili
pursu
initi
antivir
treatment
onset
symptom
discontinu
diagnost
test
result
neg
influenza
anoth
feasibl
manag
strategi
influenza
vaccin
month
transplant
recommend
hsct
recipi
studi
incid
influenza
similar
vaccin
nonvaccin
patient
howev
two
patient
asymptomat
influenza
infect
vaccin
suggest
activ
immun
might
significantli
attenu
cours
infect
even
prevent
role
chemoprophylaxi
influenza
peak
season
remain
controversi
even
though
univers
recommend
case
nosocomi
outbreak
first
week
vaccin
case
commun
nosocomi
outbreak
howev
popul
immunocompromis
patient
vaccin
incid
influenza
epidem
season
low
incid
might
result
strict
isol
polici
daili
use
surgic
mask
particular
attent
hand
hygien
togeth
virusspecif
attack
rate
may
vari
annual
addit
low
progress
rate
lower
respiratori
tract
infect
low
mortal
vrti
observ
approxim
possibl
due
rapid
diagnosi
earli
start
antivir
h
onset
symptom
therefor
popul
low
incid
mortal
consider
possibl
acquir
resist
antivir
report
epidem
earli
diagnosi
postexposur
prophylaxi
close
contact
seem
prefer
gener
chemoprophylact
strategi
molecular
assay
particularli
conveni
diagnosi
vrti
immunocompromis
patient
rapid
sensit
may
detect
multipl
pathogen
although
alway
virus
includ
assay
howev
may
also
detect
viral
genet
materi
resolv
subclin
infect
optim
manag
case
remain
unclear
cohort
nine
asymptomat
subject
vrti
isol
measur
appli
case
one
patient
treat
influenza
report
asymptomat
patient
lower
quantiti
viru
might
present
transmiss
might
improb
demonstr
observ
transmiss
household
contact
occur
asymptomat
immunocompet
subject
rhinoviru
also
studi
asymptomat
patient
subsequ
develop
clinic
symptom
strength
studi
includ
prospect
standard
diagnost
approach
outpati
regardless
respiratori
symptom
use
sensit
diagnost
method
limit
singlecentr
experi
short
observ
period
includ
last
week
infect
could
occur
thu
data
incid
extrapol
popul
season
addit
sensit
detect
respiratori
virus
may
vari
oropharyng
nasopharyng
specimen
although
nasopharyng
aspir
may
sensit
especi
convent
diagnost
method
less
invas
specimen
collect
techniqu
also
accept
given
high
sensit
new
molecular
diagnost
method
recent
guidelin
recommend
combin
intranas
sampl
use
flock
swab
pharyng
swab
one
viru
transport
medium
final
centr
differ
manag
strategi
outpati
includ
differ
contact
prevent
measur
might
experi
differ
rate
nosocomi
transmiss
morbid
conclus
vrti
frequent
patient
haematolog
malign
may
occur
presenc
classic
symptom
fever
signific
overlap
symptom
circul
period
influenza
rsv
rhinoviru
thu
empir
treatment
influenza
presenc
ili
might
reserv
sever
ill
patient
rapid
virolog
diagnosi
treatment
case
document
infect
found
feasibl
success
set
highrisk
haematolog
outpati
